Methylation of STK11 Promoter Is a Risk Factor for Tumor Stage and Survival in Clear Cell Renal Cell Carcinoma

Oncology Letters - Greece
doi 10.3892/ol.2017.6534
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Down-Regulation of TCF21 Is Associated With Poor Survival in Clear Cell Renal Cell Carcinoma

Neoplasma
Cancer Research
2012English

IKBKB Expression in Clear Cell Renal Cell Carcinoma Is Associated With Tumor Grade and Patient Outcomes

Oncology Reports
MedicineCancer ResearchOncology
2018English

Clear Cell Papillary Renal Cell Carcinoma

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2019English

Early-Stage Clear Cell Tubulopapillary Renal Cell Carcinoma: Imaging Features and Distinction From Clear Cell and Papillary Subtypes

Abdominal Radiology
Nuclear MedicineRadiologyUrologyUltrasound TechnologyGastroenterologyRadiologicalImaging
2016English

The Two Glycolytic Markers GLUT1 and McT1 Correlate With Tumor Grade and Survival in Clear-Cell Renal Cell Carcinoma

PLoS ONE
Multidisciplinary
2018English

High-Level Expression of Notch1 Increased the Risk of Metastasis in T1 Stage Clear Cell Renal Cell Carcinoma

PLoS ONE
Multidisciplinary
2012English

Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC)

PLoS ONE
Multidisciplinary
2015English

Lamin‑B1 Is a Senescence‑associated Biomarker in Clear‑cell Renal Cell Carcinoma

Oncology Letters
Cancer ResearchOncology
2019English

Overexpression of IL-32 Is a Novel Prognostic Factor in Patients With Localized Clear Cell Renal Cell Carcinoma

Oncology Letters
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy